WAMA Diagnostics (Switzerland) SA

WAMA Diagnostics (Switzerland) SA is on mission to optimize diagnosis by introducing multiplex immunoassays, thereby enabling optimal care for patients in need. Our goal is to become a center of development of innovative IVD tests for any company from this field. WAMA CH is in final stage of development of an immunoassay that will empower blood banks, biopharmaceutical companies specializing in plasma-derived protein therapeutics and clinical analysis laboratories to screen effectively and accurately all mandatory and additional transfusion-transmissible infections pathogens in a single reaction. This is a planar multiplex with chemiluminescence readouts.